Compare, Analyse IPCA Labs with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs TEVA PHARMA (Israel) - Comparison Results

IPCA LABS     Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 IPCA LABS   TEVA PHARMA
EQUITY SHARE DATA
    IPCA LABS
Mar-19
TEVA PHARMA
Dec-13
IPCA LABS/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0423,136-   
Low Rs5902,725-   
Sales per share (Unadj.) Rs298.61,800.0-  
Earnings per share (Unadj.) Rs35.0112.4-  
Cash flow per share (Unadj.) Rs49.4257.9-  
Dividends per share (Unadj.) Rs3.0098.43-  
Dividend yield (eoy) %0.43.4 10.9%  
Book value per share (Unadj.) Rs247.11,999.5-  
Shares outstanding (eoy) m126.35848.00-   
Bonus/Rights/Conversions ESOS--  
Price / Sales ratio x2.71.6 167.8%   
Avg P/E ratio x23.326.1 89.5%  
P/CF ratio (eoy) x16.511.4 145.3%  
Price / Book Value ratio x3.31.5 225.3%  
Dividend payout %8.687.5 9.8%   
Avg Mkt Cap Rs m103,1082,485,030 4.1%   
No. of employees `00013.444.9 29.9%   
Total wages/salary Rs m7,8740-   
Avg. sales/employee Rs Th2,807.033,961.4 8.3%   
Avg. wages/employee Rs Th585.80-   
Avg. net profit/employee Rs Th329.02,121.5 15.5%   
INCOME DATA
Net Sales Rs m37,7321,526,394 2.5%  
Other income Rs m5770-   
Total revenues Rs m38,3091,526,394 2.5%   
Gross profit Rs m6,901418,004 1.7%  
Depreciation Rs m1,824123,380 1.5%   
Interest Rs m18929,981 0.6%   
Profit before tax Rs m5,465264,643 2.1%   
Minority Interest Rs m01,202 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-173,724 0.0%   
Tax Rs m1,042-3,231 -32.3%   
Profit after tax Rs m4,42295,353 4.6%  
Gross profit margin %18.327.4 66.8%  
Effective tax rate %19.1-1.2 -1,562.4%   
Net profit margin %11.76.2 187.6%  
BALANCE SHEET DATA
Current assets Rs m23,7781,030,921 2.3%   
Current liabilities Rs m10,975899,050 1.2%   
Net working cap to sales %33.98.6 392.7%  
Current ratio x2.21.1 188.9%  
Inventory Days Days10491 114.3%  
Debtors Days Days6696 68.7%  
Net fixed assets Rs m20,368498,554 4.1%   
Share capital Rs m2533,757 6.7%   
"Free" reserves Rs m30,9710-   
Net worth Rs m31,2241,695,534 1.8%   
Long term debt Rs m1,409780,479 0.2%   
Total assets Rs m45,5073,488,299 1.3%  
Interest coverage x30.09.8 304.9%   
Debt to equity ratio x00.5 9.8%  
Sales to assets ratio x0.80.4 189.5%   
Return on assets %10.13.6 282.0%  
Return on equity %14.25.6 251.8%  
Return on capital %17.34.9 351.3%  
Exports to sales %45.90-   
Imports to sales %16.60-   
Net fx Rs m11,0420-   
CASH FLOW
From Operations Rs m4,923243,228 2.0%  
From Investments Rs m-1,563-86,186 1.8%  
From Financial Activity Rs m-1,832-291,769 0.6%  
Net Cashflow Rs m1,528-134,726 -1.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 75.14 Rs / USD

Compare IPCA LABS With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare IPCA LABS With: DIVIS LABORATORIES  ALEMBIC PHARMA  VENUS REMEDIES  CIPLA  GSK PHARMA  



Today's Market

Indian Indices Continue Momentum; Sensex Ends 284 Points Higher(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.

Related Views On News

IPCA LABS Announces Quarterly Results (3QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 22.8% YoY). Sales on the other hand came in at Rs 11 bn (up 20.2% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (2QFY20); Net Profit Up 63.7% (Quarterly Result Update)

Nov 12, 2019 | Updated on Nov 12, 2019

For the quarter ended September 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 63.7% YoY). Sales on the other hand came in at Rs 12 bn (up 21.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

More Views on News

Most Popular

6 Charts Showing the State of Indian Financial Markets in 2020 (Sector Info)

May 26, 2020

Six charts showing how Indian financial markets have performed in 2020 so far...

Why We Picked This Smallcap Stock for a Post Coronavirus World (Profit Hunter)

May 28, 2020

Covid-19 has made it a survival of the fittest race for many companies. The ones that can adapt will thrive in a post crisis world.

Which Stocks Should You Buy, Sell, and Hold in the Market Today? (Profit Hunter)

May 21, 2020

The coronavirus led uncertainty refuses to go away from the markets. Here's what retail investors should do with their stocks...

What the RBI's Rate Cut Means for Options Traders (Fast Profits Daily)

May 25, 2020

The RBI governor has cut the repo rate to 4%. What does this mean for options traders? Find out in this video.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

How to Trade the Coronavirus Crash - Download this FREE Report Now
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

IPCA LABS SHARE PRICE


Jun 3, 2020 (Close)

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON IPCA LABS

IPCA LABS 8-QTR ANALYSIS

COMPARE IPCA LABS WITH

OTHER USEFUL LINKS

MARKET STATS